Creative Commons source reading · Women and female-athlete health
Menstrual Cycle and Hormonal Contraceptives in Female Athletes: Should Symptoms and Nutrition Matter More than Cycle Phase? A Narrative Review
Valentina Natalucci; Gioi Spinello; Tatiana Moro; Gaspare Pavei; Gennaro Boccia; Antonio La Torre; Matteo Bonato
Originally published in Nutrients · 2026-04-02
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Background: Understanding how endogenous hormonal fluctuations and exogenous hormonal modulation influence exercise-related outcomes in women is essential for developing individualized and evidence-informed training and nutritional strategies. This narrative review summarizes the endocrine physiology of the eumenorrheic menstrual cycle and hormonal contraceptive (HC) use and critically examines their implications for athletic performance, neuromuscular function, injury risk, and metabolic regulation in physically active women. Methods: A non-systematic literature search was conducted in PubMed, Scopus, and Web of Science for articles published up to January 2026. Search terms combined menstrual cycle-related, hormonal contraceptive, performance, and metabolic/nutritional keywords, and relevant studies were selected based on their…
3.2.3. Implications for Metabolic Regulation and Symptom Expression
HC use may influence metabolic responses, including substrate utilization, insulin sensitivity, and appetite regulation, although reported effects are generally modest, heterogeneous, and likely influenced by individual characteristics and contraceptive type [36,37]. Similarly, symptom expressions, such as fatigue, mood changes, gastrointestinal discomfort, or fluid retention, vary widely among users [38]. Overall, assumptions that HCs uniformly stabilize physiological or performance-related responses are not supported by current evidence. Rather than reducing variability, HCs introduce a different endocrine context within which individual metabolic and symptomatic responses emerge [39]. This reinforces the need to consider HC users as a distinct physiological population and to prioritize individualized monitoring strategies rather…
6.2. Symptoms Versus Hormonal Phase: Implications for Training Tolerance and Per
Accumulating evidence suggests that symptom burden may exert a stronger influence on perceived readiness and training quality than the menstrual cycle phase itself. Survey-based and observational studies indicate that pain, fatigue, gastrointestinal discomfort, and sleep disruption are frequently associated with reduced training output, missed sessions, and perceived performance impairments [14]. These findings provide a plausible explanation for why phase-based performance effects are often small or inconsistent at the group level despite biologically plausible endocrine mechanisms. In applied settings, athletes often report that performance limitations coincide with periods of heightened symptoms rather than with a specific endocrine phase. Symptoms may also impair concentration and cognitive-motor control, potentially influencing…
Editorial reading guide
- Was the study designed for the population to which its conclusion is applied?
- What safeguard, access need or equity consequence should shape implementation?
